Latest News

Testing Parkinson's disease immune-based drugs: New models

Using powerful, newly developed cell culture and mouse models of sporadic Parkinson?s disease (PD), researchers have demonstrated that immunotherapy with specifically targeted antibodies may block the development and spread of PD pathology in the brain. By intercepting the distorted and misfolded alpha-synuclein (?-syn) proteins that enter and propagate in neurons, creating aggregates, the researchers prevented the development of pathology and also reversed some of the effects of already-existing disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Patients with mental illness less likely to receive diet, exercise advice

  • Many transplant surgeons in U.S. suffer burnout, research suggests

  • Role of specialized protein affirmed in assuring normal cell development

  • People with disabilities experience unrecognized health disparities, new research shows

  • Strong connection between violence, mental illness in Guatemala during civil war lessens in postwar period

  • Why debunked autism treatment fads persist

  • Adults wtih disabilities screened for cancer less often

  • Can coffee reduce your risk of MS?

  • Optogenetic stimulation of the brain to control pain demonstrated in study

  • Emergency doctors and paramedics commonly misinterpret documents for end-of-life care choices, study finds

  •